Printer Friendly
The Free Library
5,676,445 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Sorin Group: ELA Medical, Inc. Files PMA Submission for Ovatio(TM) CRT.


ELA Medical, Inc, a Sorin Group Company, Has Filed a Pre-Market Approval with the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 for the Smallest CRT-D Available to Patients Outside the US

ARVADA, Colo. -- Ela Medical, Inc., a Sorin Group (MIL:SRN) Company and a member of the Sorin Group Cardiac Rhythm Management Cardiac rhythm management is a field of treatment in cardiology. The purpose is managing cardiac rhythm disorders. Usually it involves artificial pacemakers and/or implantable cardioverter-defibrillator therapy as well as antiarrhythmia drugs.  (CRM) Business Unit, today announced that it has filed a pre-market approval application (PMA PMA (papillary-marginal-attached),
n a system of epidemiologic scoring of periodontal disease devised by Schour and Massler in which the symbols denote the areas involved in gingival inflammation.

PMA Progressive muscular atrophy
) with the United States Food and Drug Administration United States Food and Drug Administration (FDA),
n.pr a unit of the Public Health Service created to protect the health of the nation against impure and unsafe foods, drugs, and cosmetics.
 (FDA) seeking approval to market OVATIO[TM] CRT (1) (C RunTime) See runtime library.

(2) (Cathode Ray Tube) A vacuum tube used as a display screen in a computer monitor or TV. The viewing end of the tube is coated with phosphors, which emit light when struck by electrons.
, its latest cardiac resynchronization therapy defibrillator (CRT-D).

OVATIO CRT is currently the smallest CRT-D available to patients outside the U.S. Its reduced size and unique features are aimed at improving patient comfort.

Cardiac resynchronization therapy defibrillators are indicated in heart failure patients who might be at risk for Sudden Cardiac Death Sudden Cardiac Death Definition

Sudden cardiac death (SCD) is an unexpected death due to heart problems, which occurs within one hour from the start of any cardiac-related symptoms. SCD is sometimes called cardiac arrest.
 (SCD). CRT-D devices are capable of resynchronizing the contractions of the ventricles (the heart's lower chambers) by delivering low-energy impulses to the heart as well as providing patients with defibrillation Defibrillation Definition

Defibrillation is a process in which an electronic device sends an electric shock to the heart to stop an extremely rapid, irregular heartbeat, and restore the normal heart rhythm.
 support when abnormally fast, life-threatening heart rhythms occur.

With 550,000 new cases diagnosed annually in the United States, heart failure is the most costly cardiovascular disease. Approximately $40 billion are dedicated annually to the treatment of this debilitating de·bil·i·tat·ing
adj.
Causing a loss of strength or energy.


Debilitating
Weakening, or reducing the strength of.

Mentioned in: Stress Reduction
 condition.

Andre-Michel Ballester, President of Sorin Group Cardiac Rhythm Management (CRM) Business Unit commented: "Sorin Group is pleased to file this application with the FDA for what would be the first CRT-D device that the company will market in the U.S. We look forward to working with the Agency through this review process."

Sorin Group:

Sorin Group CRM Business Unit (www.sorin-crm.com) designs and manufactures implantable pacemakers and ICDs, leads and Holter equipment and markets them worldwide.

Sorin Group (Reuters code: SORN.MI), a world leader in the development of medical technologies for cardiac surgery, offers innovative therapies for cardiac rhythm dysfunctions, interventional cardiology and the treatment of chronic kidney diseases. Sorin Group includes: Dideco, CarboMedics, Inc., COBE Cardiovascular, Inc., St[?]ckert, Mitroflow, ELA Medical, Inc., Sorin Biomedica, Bellco and Soludia. Sorin Group has more than 4,500 employees working at facilities in more than 80 countries throughout the world to serve over 5,000 public and private treatment centers.

For more information: www.sorin.com
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 7, 2006
Words:365
Previous Article:Shelbourne Development Files New Design of "The Chicago Spire" with the City of Chicago.
Next Article:Photoshop Professional Highlights the 2007 Macworld Market Symposiums Line-Up.
Topics:



Related Articles
St. Jude Medical Updates Status of U.S. Regulatory Filings for the RHYTHM ICD Study.
Inamed Receives FDA Letter Requesting Additional Information for Its Style 410 Cohesive Gel Breast Implant PMA Application.
INAMED Provides Update on Its U.S. Silicone Gel Filled Breast Implant Regulatory Activities and Clinical Studies.
Medtronic Submits First PMA Module to the U.S. Food and Drug Administration for Endeavor(TM) Drug-Eluting Coronary Stent; Module Submission is First...
Medtronic Reports Second Quarter Revenue Growth of 15% and 23% Growth in Diluted EPS Before Special Items; After Special Items, as Reported Diluted...
Medtronic Provides Update on U.S. Obesity Trial; SHAPE Trial Does Not Meet Efficacy Endpoint; Medtronic to Continue Clinical Trials for Obesity--a...
Clinical Trial Shows Device Optimizes Cardiac Resynchronization Therapy in Less Than Two Minutes; St. Jude Medical Announces QuickOpt Optimization...
Medtronic Submits Final PMA Modules to FDA for Approval of the Endeavor Drug-Eluting Coronary Stent System.
Mentor Receives FDA Approval to Sell Its MemoryGel(TM) Breast Implants; Announces Conference Call to Discuss Approval.
Sorin Group Enters into an Exclusive Agreement with Datascope to Distribute Sorin's Peripheral Stent Line.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles